Home / Inspections / 986929

FDA Inspection 986929 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company — FEI 2650089

The FDA completed an inspection of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on May 18, 2016 in Manati, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Manati, PR (United States)

Facility

Other inspections at this facility

  • 1147009 (VAI Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110480 (VAI Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079769 (OAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030016 (VAI Mon Sep 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 949087 (NAI Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources